Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

Name: Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
Published: 2018
License: Public Domain

University of Southern California · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

extrahepatic bile duct adenocarcinoma, biliary type, gallbladder adenocarcinoma, biliary type, metastatic pancreatic adenocarcinoma, recurrent cholangiocarcinoma, recurrent gallbladder carcinoma, recurrent hepatocellular carcinoma, recurrent intrahepatic cholangiocarcinoma, recurrent pancreatic carcinoma, stage iii gallbladder cancer ajcc v7, stage iii hepatocellular carcinoma ajcc v7, stage iii intrahepatic cholangiocarcinoma ajcc v7, stage iii pancreatic cancer ajcc v6 and v7

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 886466
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.